Literature DB >> 10951287

Biochemical characterization of S100A2 in human keratinocytes: subcellular localization, dimerization, and oxidative cross-linking.

R Deshpande1, T L Woods, J Fu, T Zhang, S W Stoll, J T Elder.   

Abstract

S100A2 is a calmodulin-like protein of unknown function, whose transcription is positively regulated in response to ErbB and p53 signaling. Expression of S100A2 is markedly increased in the context of ErbB-driven reactive epidermal hyperplasia, and decreased in the context of hypofunctional p53 mutations in carcinoma cell lines and tumors. This bimodal pattern of regulation suggests an important function for S100A2 in keratinocyte differentiation and carcinogenesis. Taking the biochemical approach to the determination of S100A2 function, we have characterized its physical state and subcellular localization in normal human keratinocytes. S100A2 in hypotonic lysates remained soluble after centrifugation at 100 000 x g, indicating that it is not associated with cell membranes. Permeabilization experiments confirmed the lack of membrane association and revealed a digitonin-insoluble nuclear fraction of S100A2, which was confirmed by immunofluorescence microscopy. Pulldown assays of epitope-tagged S100A2 and yeast two-hybrid screening revealed that S100A2 displays a strong propensity to homodimerize. Naturally expressed S100A2 dimers in normal human keratinocytes readily underwent intermolecular disulfide cross-linking unless a strong denaturant was present during cell lysis. Treatment of intact normal human keratinocytes with hydrogen peroxide strongly promoted S100A2 cross-linking. These results demonstrate that native S100A2 is a homodimer that does not depend on disulfide cross-linking for stability, but undergoes intermolecular cross-linking at cysteine residues in response to oxidative stress. Based on these findings, we propose that S100A2 may protect normal keratinocytes against carcinogens by participating in the cellular proof-reading response to oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951287     DOI: 10.1046/j.1523-1747.2000.00078.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  Clinical significance of S100A2 expression in gastric cancer.

Authors:  Ying-Fu Liu; Qing-Qing Liu; Xuan Wang; Chun-Hua Luo
Journal:  Tumour Biol       Date:  2013-12-07

2.  Expression of calcium-binding proteins S100A2 and S100A4 in Barrett's adenocarcinomas.

Authors:  Ok-Jae Lee; Seung-Mo Hong; Mohammad H Razvi; Dunfa Peng; Steven M Powell; Mark Smoklin; Christopher A Moskaluk; Wael El-Rifai
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

3.  Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes.

Authors:  S W Stoll; S Kansra; S Peshick; D W Fry; W R Leopold; J F Wiesen; M Sibilia; T Zhang; Z Werb; R Derynck; E F Wagner; J T Elder
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

4.  Electrospray low energy CID and MALDI PSD fragmentations of protonated sulfinamide cross-linked peptides.

Authors:  Mark J Raftery; Carolyn L Geczy
Journal:  J Am Soc Mass Spectrom       Date:  2002-06       Impact factor: 3.109

Review 5.  Influence of S100A2 in Human Diseases.

Authors:  Hitomi Sugino; Yu Sawada
Journal:  Diagnostics (Basel)       Date:  2022-07-20

6.  Transcriptomic Analysis of the Porcine Gut in Response to Heat Stress and Dietary Soluble Fiber from Beet Pulp.

Authors:  Minju Kim; Eugeni Roura; Yohan Choi; Joeun Kim
Journal:  Genes (Basel)       Date:  2022-08-16       Impact factor: 4.141

7.  Prognostic significance of different immunohistochemical S100A2 protein expression patterns in patients with operable nonsmall cell lung carcinoma.

Authors:  Panagiotis Hountis; Periklis G Foukas; Dimitrios Matthaios; Maria Kefala; Leonidas Chelis; Aikaterini Pantelidaki; Ioannis G Panayiotides; Petros Karakitsos; Stylianos Kakolyris
Journal:  Onco Targets Ther       Date:  2012-11-21       Impact factor: 4.147

8.  Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site.

Authors:  Ralf D Kirschner; Katja Sänger; Gerd A Müller; Kurt Engeland
Journal:  Nucleic Acids Res       Date:  2008-04-03       Impact factor: 16.971

9.  Prognostic Roles of mRNA Expression of S100 in Non-Small-Cell Lung Cancer.

Authors:  Ying Liu; Jian Cui; Yun-Liang Tang; Liang Huang; Cong-Yang Zhou; Ji-Xiong Xu
Journal:  Biomed Res Int       Date:  2018-01-21       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.